# Compass Therapeutics, Inc.: Form 8-K, filed Jun 11, 2026

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2026-06-11
- Accepted by EDGAR: Jun 11, 2026, 16:00 ET
- Period: 2026-06-10
- Accession: 0001171843-26-004068
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000117184326004068/f8k_061126.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000117184326004068/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000117184326004068/f8k_061126.htm

Filed Jun 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-004068. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.